Work

Abstract CT254: A first-in-human phase 1 study of the safety and pharmacokinetics of XB002 in patients with inoperable locally advanced or metastatic solid tumors

Year: 2022

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2022-ct254

Authors: Melissa Johnson, Susanna Ulahannan, Andrae Vandross, Haeseong Park, Leo Faoro, Raffaella Faggioni, Jing Li, Yu-Lin Chang, Shailaja Uttamsingh, Anthony Tolcher

Institutions: Sarah Cannon, Tennessee Oncology, OU Health Stephenson Cancer Center, Washington University in St. Louis, Exelixis (United States)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4282925038

Cites:

Cited by: 2

Related to: 10